Key result
Parental history of diabetic nephropathy was not associated with altered endothelial function, including vasodilation to acetylcholine (P=0.75), in healthy offspring of Type 1 diabetic patients.
Why the study?
Is endothelial dysfunction present in healthy offspring of Type 1 diabetic patients with end-stage renal disease compared to those without nephropathy?
Case-Control (n=24)
Is endothelial dysfunction present in healthy offspring of Type 1 diabetic patients with end-stage renal disease compared to those without nephropathy?
p-value: p=0.75
Endothelial dysfunction does not appear to explain the familial aggregation of diabetic nephropathy in offspring of patients with Type 1 diabetes.
No endothelial dysfunction link in offspring; leaves open alternative mechanisms for familial diabetic nephropathy aggregation in Type 1 diabetes.
AIMS: Familial aggregation of diabetes and nephropathy has been observed in several populations. Various interpretations have included underlying genetic mechanisms possibly mediated by a predisposition to hypertension. Endothelial dysfunction is now recognized as central to these conditions and offers a unifying mechanism to explain the disease aggregation. To test this hypothesis, we have examined endothelial function in healthy subjects at differing risks for diabetic nephropathy. METHODS: Endothelial function was assessed in 12 healthy offspring (nine male (M)/three female (F); age 25.8+/-1.2 years, mean +/- SEM) of parents with Type 1 diabetes mellitus (DM) and end-stage renal disease compared with 12 control offspring (9 M/3 F; age 26.3+/-1.3 years) of parents with long duration (>20 years) Type 1 DM but without evidence of nephropathy. Forearm blood flow responses to brachial artery infusion of acetylcholine (endothelium-dependent), sodium nitroprusside (endothelium-independent), noradrenaline and the competitive inhibitor of basal nitric oxide release N(G)-monomethyl-L-arginine were assessed using venous occlusion plethysmography. RESULTS: There were no significant differences between the groups in von Willebrand factor, fasting plasma glucose (4.2+/-0.1 vs. 4.0+/-0.2 mmol/l) or in 24-h ambulatory blood pressure. Similarly, the groups did not differ in vasodilation to acetylcholine (P = 0.75) and sodium nitroprusside (P = 0.79) or in vasoconstriction to noradrenaline (P = 0.45) and N(G)-monomethyl-L-arginine (P = 0.30). CONCLUSION: These data do not support a role for endothelial dysfunction in the familial aggregation of diabetic nephropathy.
No takes yet. Share an insight, caveat, or question.
McAllister et al. (1999) conducted a case-control in Familial risk of diabetic nephropathy (n=24). Parental Type 1 diabetes with end-stage renal disease vs. Parental Type 1 diabetes without nephropathy was evaluated on Vasodilation to acetylcholine (endothelium-dependent) (p=0.75). Parental history of diabetic nephropathy was not associated with altered endothelial function, including vasodilation to acetylcholine (P=0.75), in healthy offspring of Type 1 diabetic patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: